SCHEMBL5517320

SCHEMBL5517320

Cc1sc(C(C)C)nc1CC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRR1 P24046 1/20 0.36
GAA P10253 2/20 0.35
KDM4E B2RXH2 2/20 0.34
AKR1B1 P15121 3/20 0.34
AGBL2 Q5U5Z8 2/20 0.33
CTSA P10619 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518909 0.81 PKM (0.34) GABRR1GAAKDM4EAKR1B1ALDH1A1
SCHEMBL5517237 0.81 PTGDR2 (0.36) GABRR1KDM4EAKR1B1ALDH1A1MAPT
SCHEMBL5521343 0.81 GCK (0.36) GABRR1GAAAKR1B1ALDH1A1NPC1
SCHEMBL4093001 0.79 GABRR1 (0.39) GABRR1GAAKDM4EAGBL2CTSA
SCHEMBL10130052 0.77 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL855931 0.77 SLC6A3 (0.41) GABRR1GAAKDM4EAGBL2ALDH1A1
SCHEMBL5513251 0.77 AKR1B1 (0.32) AKR1B1
SCHEMBL5516134 0.75 PTGDR2 (0.40) GAAKDM4EALDH1A1MAPTPTGDR2
SCHEMBL17480641 0.75 PTPRB (0.30)
SCHEMBL5514684 0.74 KDM4E (0.49) GAAKDM4EAKR1B1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed